Clinical Trials Logo

Clinical Trial Summary

This study aims is to evaluate, two hours after a single administration, the rate of sustained response produced by the association Geolab consisting of acetylsalicylic acid, sodium bicarbonate and anhydrous citric acid - oral powder, with the active comparator acetylsalicylic acid (Aspirin ® -- Bayer) - a simple tablet for the treatment of acute pain in patients with mild to moderate CTTE, using for both the visual analog scale pain - VAS.


Clinical Trial Description

The secondary objectives of the study are to evaluate:

- Modification of gastric pH after administration of drugs by measuring with gastroesophageal pH Monitor, comparing the results between the groups;

- The incidence of administration of rescue medications, through the accounts of patients and researchers, comparing the results between the groups;

- The percentage of improvement in time 30, 60, 90 and 120 minutes after administration, using the visual analog scale (VAS), comparing the results between the groups;

- Evaluate the gastric symptoms before and after treatment by clinical investigation of patients, comparing the results between the groups;

- Evaluate the change in associated symptoms (photophobia, phonophobia, nausea, vomiting), using 4-point scale (0 - absent 1 - mild 2 - moderate 3 - severe), comparing the results between the groups;

- Assess the quantitative and qualitative parameters related to adverse reactions, comparing the results between the groups. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01012349
Study type Interventional
Source L.A.L Clinica Pesquisa e Desenvolvimento Ltda.
Contact alexandre Frederico, physician
Phone 55 19 3829-3822
Email dr.alexandre@alclinica.com.br
Status Not yet recruiting
Phase Phase 2/Phase 3
Start date February 2011
Completion date August 2011